Indonesia Urges Greater Transparency in Cross-Border Copyright Royalty Governance Before 35 Countries 
SaunaKits.com Opens Its Upstate South Carolina Showroom, Bringing Hands-On Sauna Shopping to the Southeast 
Encore Construction Shares Guidance to Help Homeowners Avoid Costly Water Damage Insurance Claim Mistakes Adverum Appoints Christopher J. DeRespino as Chief Business Officer
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
Phase 2/3 trial will enroll approximately 4,000 healthy pregnant women in the U.S., Canada, Argentina,…
CBD Companies Will Lose Market Share to Delta 8 THC Hemp Products in 2021
Las Vegas, Feb. 18, 2021 (GLOBE NEWSWIRE) — When the mainstream thinks of marijuana, they…
Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using…
Turning Point Therapeutics to Host Fourth Quarter and Full-Year 2020 Conference Call
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Courtney Barton Joins Arcutis as Chief Compliance Officer and Chief of Staff
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a…
GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences…
Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopia
Nyxol and Low-Dose (0.4%) Pilocarpine Combination to Target Improvement in Near Vision in a Presbyopic…
Alimera Sciences Continues Global Geographic Expansion With Launch of ILUVIEN in Finland for Both Indications
ATLANTA, Feb. 18, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical…
Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
WATERTOWN, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage…
Pliant Therapeutics to Participate in Upcoming Virtual Investor Events
SOUTH SAN FRANCISCO, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Albireo to Report Q4 and Year-End 2020 Financial Results on February 25
Conference call and webcast to be held at 10:00 a.m. ET BOSTON, Feb. 18, 2021…
Allogene Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Coherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24th
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or “the…
Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate Finance Executives to the Board of Directors
MIAMI, Feb. 18, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
TRACON to Report Fourth Quarter and Full Year 2020 Financial Results and Company Highlights on February 25, 2021
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical…
Single-Dose Radiation Therapy for Breast Cancer Removes Treatment Barriers for Underserved Black Women
TARGIT Collaborative Group Advocates Wider Adoption of TARGIT-IORT to Address Racial Disparities and Reduce Compliance…
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19
Labcorp Using PacBio’s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S. MENLO PARK, Calif.,…
Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety
Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety Lugano, Switzerland,…
Rubius Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…